Concentration-Dependent Antibacterial Activity of Chitosan on Lactobacillus plantarum

Abstract

The antimicrobial effect of chitosan and synthetic chitosan derivatives has been confirmed on many Gram-positive and Gram-negative bacteria and fungi. The tests were carried out on pathogenic microorganisms, so the mechanism and concentration dependence of the inhibitory effect of chitosan were revealed. We conducted our tests on a probiotic strain, Lactobacillus plantarum. Commercially available chitosan derivatives of different molecular weights were added to L. plantarum suspension in increasing concentrations. The minimum inhibitory concentration (MIC) value of chitosan was determined and confirmed the viability decreasing effect at concentrations above the MIC with a time-kill assay. The release of bacterium cell content was measured at 260 nm after treatment with 0.001–0.1% concentration chitosan solution. An increase in the permeability of the cell membrane was observed only with the 0.1% treatment. The interaction was also investigated by zeta potential measurement, and the irreversible interaction and concentration dependence were established in all concentrations. The interaction of fluorescein isothiocyanate (FITC) labeled low molecular weight chitosan and bacterial cells labeled with membrane dye (FM® 4–64) was confirmed by confocal microscopy. In conclusion, the inhibitory effect of chitosan was verified on a probiotic strain, which is an undesirable effect in probiotic preparations containing chitosan additives, while the inhibitory effect experienced with pathogenic strains is beneficial.

Benzothiazole Derivatives of Chitosan and Their Derived Nanoparticles: Synthesis and In Vitro and In Vivo Antibacterial Effects

“…We used the classical method based on the fact that bacteria with a damaged cell wall release content into the external environment, and this content intensively absorbs at 260 nm. Therefore, the greater the absorption at 260 nm, the more damaged bacteria are in the treated suspension [ 60 ].…”

“…Typically, natural polysaccharides, including chitosan, have dramatically low toxicity and are considered non-toxic biopolymers [ 60 ]. However, the introduction of a new substituent into the chitosan macromolecule can change the toxic characteristics of the resulting polymer [ 61 ].…”

First Synthesis of DBU-Conjugated Cationic Carbohydrate Derivatives and Investigation of Their Antibacterial and Antifungal Activity

“…Green (525/30 nm) and red (695/50 nm) fluorescence channels were used to gate out the cells on a green versus red dot plot. The ratio of the SYTOX green (SG) positive bacterial cells was evaluated [ 54 ].…”

Flavonoid-Labeled Biopolymer in the Structure of Lipid Membranes to Improve the Applicability of Antioxidant Nanovesicles

“…The development of biofunctional materials based on biopolymers and lipids has been of great scientific and technological interest in recent years [ 1 , 2 , 3 , 4 ]. Chitosan consists of a polysaccharide of natural origin, and is biodegradable, non-toxic, non-antigenic, biocompatible and has antimicrobial activities [ 5 , 6 , 7 ]. These properties make chitosan a polymer of real applicability in association with liposomes, especially considering the improvement of characteristics such as stability, especially in the gastrointestinal tract, and the retention of encapsulated material and specificity for biomedical applications when bioadhesion is required [ 8 , 9 , 10 , 11 ].…”